Research

Medical Sciences

Title :

Assessing the role of microRNAs in clinical severity of thalassemia patients, and in hydroxyurea mediated HbF induction

Area of research :

Life Sciences & Biotechnology, Medical Sciences

Focus area :

Thalassemia

Principal Investigator :

Dr. Anita Nadkarni, Scientist, National Institute of Immunohaematology, Mumbai, Maharashtra

Timeline Start Year :

2017

Contact info :

Details

Total Budget (INR):

 51,88,496

Organizations involved

Implementing Agency :

National Institute of Immunohaematology, Mumbai, Maharashtra

Funding Agency :

Science and Engineering Research Board (SERB),Department of Science & Technology (DST),Government of India

Related Research

A phase III randomized study comparing two adjuvant hypofractionated radiation schedules in patients with breast cancer
Adaptive immune responses in human Shigellosis using human mini-intestines
Altered microRNA and its targets in glioblastoma cell lines
Alternate test protocols to minimize number of tests
An event-driven, phase 3, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficiency, safety, immunogenicity, & lot-to-lot consistency of Bbv152, a whole-varion inactivated Sars-Cov-2 vaccine in adults more than 18 to years of age